The Ambidirectional Cohort Study of Neurovascular Complications After Radiation Therapy in Head and Neck Cancer Patients
Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usually the standard treatment of Head and neck cancers. In the present study, investigators aim to study the prevalence of cervical-cranial vascular complications during the early stages in these Head and neck cancer patients receiving Radiotherapy. Investigators will also compare the results between Nasopharyngeal cancer and other Head and neck cancerpatients receiving Radiotherapy.
• Age ≥20 years.
• Head and neck cancer patient .
• Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry.
• Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment.
• Age ≥20 years.
• Head and neck cancer patient.
• Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site.
• Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\
⁃ 10 years after RT, one within 5 years after RT, the other after 5 years after RT.